EVOTEC SE - ADR
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About EVO
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Find out what a historical investment in EVOTEC SE - ADR would be worth today using our EVO stock calculator.
$1.30B
-
0.00%
494.08K
$3.74
$3.59
$3.74
$7.77
$2.84
Ready to start your investing journey with Stake?
Open an accountEVO FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in EVO
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in EVO
on Stake
Buy EVO from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of EVO from only US$10 with fractional shares
